Awasthi M, Upadhyay AK, Singh S, Pandey VP, Dwivedi UN (2017) Terpenoids as promising therapeutic molecules against Alzheimer’s disease: amyloid beta- and acetylcholinesterase-directed pharmacokinetic and molecular docking analyses. Mol Simul 44:1–11. https://doi.org/10.1080/08927022.2017.1334880

Article  CAS  Google Scholar 

Binder LI, Frankfurter A, Rebhun LI (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101(4):1371–1378

Article  PubMed  CAS  Google Scholar 

Borah K, Bora K, Mallik S, Zhao Z (2022) Potential therapeutic agents on Alzheimer’s disease through molecular docking and molecular dynamics simulation study of plant-based compounds. Chem Biodivers. https://doi.org/10.1002/cbdv.202200684

Article  PubMed  Google Scholar 

Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD, Salmon JK, Shan Y, Shaw DE (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the ACM/IEEE Conference on Supercomputing (SC06), Tampa, Florida, , November 11–17

Chakraborty B, Mukerjee N, Maitra S, Zehravi M, Mukherjee D, Ghosh A, Massoud EE, Rahman MH (2022) Therapeutic potential of different natural products for the treatment of Alzheimer’s disease. Oxid Med Cell Longev 2022(1):6873874

Chou K-C (2004) Insights from modeling the tertiary structure of human BACE2. J Proteome Res 3:1069–1072. https://doi.org/10.1021/pr049905s

Article  PubMed  CAS  Google Scholar 

Cipriani G, Dolciotti C, Picchi L, Bonuccelli U (2011) Alzheimer and his disease: a brief history. Neurol Sci 32(2):275–279

Article  PubMed  Google Scholar 

Sharmila DHM, Srihari M, Prabhu P, Balakrishnan R, Sabapathi SN (2025) Network Pharmacology and molecular docking analysis of chrysoeriol for Alzheimer’s disease. BIO Web Conf 172:02009. https://doi.org/10.1051/bioconf/202517202009

Danysz W, Parsons CG (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease: preclinical evidence. Int J Geriatr Psychiatry. https://doi.org/10.1002/gps.938

Article  PubMed  Google Scholar 

Devi P, Syad AN (2014) Botanics: a potential source of new therapies for Alzheimer's disease? Botanics Targets and Therapy 11. https://doi.org/10.2147/btat.s33554

Drechsel DN, Hyman AA, Cobb MH, Kirschner MW (1992) Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 3(10):1141–54

Dumont M, Wille E, Calingasan NY, Tampellini D, Williams C, Gouras GK, Liby K, Sporn M, Beal MF, Lin MT (2009) Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer’s disease. J Neurochem 109:502–512. https://doi.org/10.1111/j.1471-4159.2009.05970.x

Article  PubMed  PubMed Central  CAS  Google Scholar 

Elangovan ND, Dhanabalan AK, Gunasekaran K, Kandimalla R, Sankarganesh D (2020) Screening of potential drug for Alzheimer’s disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation. J Biomol Struct Dyn 39:7065–7079. https://doi.org/10.1080/07391102.2020.1805362

Article  PubMed  CAS  Google Scholar 

El-Hachem N, Haibe-Kains B, Khalil A, Kobeissy FH, Nemer G (2017) Autodock and AutodockTools for protein-ligand docking: beta-site amyloid precursor protein cleaving enzyme 1(BACE1) as a case study. Methods Mol Biol 391–403:391. https://doi.org/10.1007/978-1-4939-6952-4_20

Article  CAS  Google Scholar 

Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ (2016) Computational protein–ligand docking and virtual drug screening with the autodock suite. Nat Protoc 11:905–919. https://doi.org/10.1038/nprot.2016.051

Article  PubMed  PubMed Central  CAS  Google Scholar 

Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shaw DE, Shelley M, Perry JK, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749

Article  PubMed  CAS  Google Scholar 

Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177–6196

Article  PubMed  CAS  Google Scholar 

Gaugler J, James B, Johnson T, Scholz K, Weuve J (2016) 2016 Alzheimer’s disease facts and figures includes a special report on the personal financial impact of Alzheimer’s on families. https://www.alz.org/alzheimers-dementia/facts-figures?utm_source=googlegrant&utm_medium=paidsearch&utm_campaign=google_grant&gad_source=1&gad_campaignid=42054366&gbraid=0AAAAAD14_Ng8mgT3IAnoILUppxve5oCMh&gclid=Cj0KCQjwrJTGBhCbARIsANFBfgvU5GrdNaVvgR9RsBMaAt6HEALw_wcB

Ge SX, Jung, D (2018) ShinyGO: a graphical enrichment tool for animals and plants. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/315150

Ge SX, Jung D, Yao R (2019) ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36:2628–2629. https://doi.org/10.1093/bioinformatics/btz931

Article  PubMed Central  CAS  Google Scholar 

Goodsell DS, Sanner MF, Olson AJ, Forli S (2020) TheAutoDocksuite at 30. Protein Sci 30:31–43. https://doi.org/10.1002/pro.3934

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guerguer FZ, Khedraoui M, Samadi A, Chtita S (2025) Computational approaches for multitarget drug design in Alzheimer’s disease: a comprehensive review. Curr Med Chem. https://doi.org/10.2174/0109298673320300240930064551

Article  PubMed  Google Scholar 

Guoqiang S, Yifa C, Feng X (2019) Molecular modeling study of PDE4 inhibitors based on Discovery Studio. Journal of Chemical Biological and Physical Sciences 9. https://doi.org/10.24214/jcbps.a.9.1.05566

Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. enrichment factors in database screening. J Med Chem 47:1750–1759

Article  PubMed  CAS  Google Scholar 

Iqbal D, Rehman MT, Dukhyil AB, Rizvi SMD, Ajmi MFA, Alshehri BM, Banawas S, Khan MS, Alturaiki W, Alsaweed M (2021) High-throughput screening and molecular dynamics simulation of natural product-like compounds against Alzheimer’s disease through multitarget approach. Pharmaceuticals 14:937. https://doi.org/10.3390/ph14090937

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jangid K, Devi B, Sahoo A, Kumar V, Dwivedi AR, Thareja S, Kumar R, Kumar V (2023) Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer’s disease. J Biomol Struct Dyn 42:509–527. https://doi.org/10.1080/07391102.2023.2201838

Article  PubMed  CAS  Google Scholar 

Jiang Z-Y, Lu M-C, Xu L, Yang T-T, Xi M-Y, Xu X-L, Guo X-K, Zhang X-J, You Q-D, Sun H-P (2014) Discovery of potent KEAP1–NRF2 protein–protein interaction inhibitor based on molecular binding determinants analysis. J Med Chem 57:2736–2745. https://doi.org/10.1021/jm5000529

Article  PubMed  CAS  Google Scholar 

Kochanek KD, Murphy SL, Xu J, Tejada-Vera B (2016Jun) Deaths: Final Data for 2014. Natl Vital Stat Rep. 65(4):1–122 (PMID: 27378572)

PubMed  Google Scholar 

Kumar A, Nisha CM, Silakari C, Sharma I, Anusha K, Gupta N, Nair P, Tripathi T, Kumar A (2015) Current and novel therapeutic molecules and targets in Alzheimer’s disease. J Formos Med Assoc 115:3–10. https://doi.org/10.1016/j.jfma.2015.04.001

Article  PubMed  CAS  Google Scholar 

Liby K, Hock T, Yore MM, Suh N, Place AE, Risingsong R, Williams CR, Royce DB, Honda T, Honda Y, Gribble GW, Hill-Kapturczak N, Agarwal A, Sporn MB (2005) The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of HEME oxygenase-1 and NRF2/ARE signaling. Cancer Res 65:4789–4798. https://doi.org/10.1158/0008-5472.can-04-4539

Article  PubMed  CAS  Google Scholar 

Liu J, Li T, Zhong G, Pan Y, Gao M, Su S, Liang Y, Ma C, Liu Y, Wang Q, Shi Q (2023) Exploring the therapeutic potential of natural compounds for Alzheimer’s disease: mechanisms of action and pharmacological properties. Biomed Pharmacother 166:115406. https://doi.org/10.1016/j.biopha.2023.115406

Article  PubMed  CAS  Google Scholar 

Lo S-C, Li X, Henzl MT, Beamer LJ, Hannink M (2006) Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO J 25:3605–3617. https://doi.org/10.1038/sj.emboj.7601243

Article  PubMed  PubMed Central  CAS  Google Scholar 

MBiotek UBSS, Muscifa ZS, Destiarani W, Rohmatullah FG, Yusuf M (2023) Molecular interaction analysis and visualization of protein-ligand docking using Biovia discovery studio visualizer. Indones J Comput Biol (IJCB) 2:22. https://doi.org/10.24198/ijcb.v2i1.46322

Article  Google Scholar 

McGaughey GB, Holloway MK (2007) Structure-guided design of β-secretase (BACE-1) inhibitors. Expert Opin Drug Discov 2:1129–1138. https://doi.org/10.1517/17460441.2.8.1129

Article  PubMed  CAS  Google Scholar 

Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785–2791.